Cervical Cancer Market Share and Growth 2019: F. Hoffmann-La Roche, GlaxoSmithKline, Merck, Advaxis Immunotherapies
Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract.
North America accounted for the largest share of the global market, followed by Europe.
View full press release